Aion Therapeutic Inc. Stock

Equities

AION

CA00905T1021

Pharmaceuticals

Market Closed - Canadian Securities Exchange 02:57:24 2024-04-24 pm EDT 5-day change 1st Jan Change
0.015 CAD 0.00% Intraday chart for Aion Therapeutic Inc. 0.00% -25.00%
Sales 2022 - Sales 2023 - Capitalization 1.47M 2.01M
Net income 2022 -3M -4.1M Net income 2023 - 0 EV / Sales 2022 -
Net Debt 2022 744K 1.02M Net Debt 2023 970K 1.33M EV / Sales 2023 -
P/E ratio 2022
-0.73 x
P/E ratio 2023
-5.7 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 88.09%
More Fundamentals * Assessed data
Dynamic Chart
Aion Therapeutic Inc. announced that it expects to receive CAD 0.75 million in funding CI
Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023 CI
Aion Therapeutic Inc. completed the acquisition of Toppen Health Inc. CI
Aion Therapeutic Inc. entered into a definitive share purchase agreement to acquire Toppen Health Inc. for $4.9 million. CI
Aion Therapeutic Inc. entered into a definitive share purchase agreement to acquire Toppen Health for $4.9 million. CI
Aion Therapeutic Inc. announced that it has received CAD 0.6425 million in funding CI
Aion Therapeutic Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023 CI
Aion Therapeutic Inc. Reports Earnings Results for the Full Year Ended April 30, 2023 CI
Aion Therapeutic Inc. announced that it has received CAD 0.4275 million in funding CI
Aion Therapeutic Announces Resignation of Rosy Mondin as Director CI
Aion Therapeutic Inc. announced that it expects to receive CAD 0.5 million in funding CI
Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023 CI
Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022 CI
Aion Therapeutic Inc. Reports Earnings Results for the First Quarter Ended July 31, 2022 CI
More news
Current month+50.00%
1 month+50.00%
3 months-25.00%
6 months-25.00%
Current year-25.00%
More quotes
1 week
0.02
Extreme 0.015
0.02
1 month
0.01
Extreme 0.01
0.02
Current year
0.01
Extreme 0.005
0.02
1 year
0.01
Extreme 0.005
0.03
3 years
0.01
Extreme 0.005
0.12
5 years
0.00
Extreme 0
0.26
10 years
0.00
Extreme 0
0.35
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 20-01-15
Director of Finance/CFO 67 18-11-30
Director/Board Member - 20-08-06
Members of the board TitleAgeSince
Chief Executive Officer 48 20-01-15
Director/Board Member - 20-08-16
Director/Board Member - 18-10-30
More insiders
Date Price Change Volume
24-04-24 0.015 -25.00% 443,666
24-04-23 0.02 0.00% 8,000
24-04-22 0.02 0.00% 305,500
24-04-19 0.02 0.00% 265,505
24-04-18 0.02 +33.33% 772,060

Delayed Quote Canadian Securities Exchange, April 24, 2024 at 02:57 pm EDT

More quotes
Aion Therapeutic Inc. is a Canada-based company, which operates within the health and wellness sector with a diverse portfolio of intellectual property. The Company, through its subsidiary, AI Pharmaceuticals Jamaica Limited, is engaged in research, development and treatment, as well as new therapeutic formulation discovery using data mining and artificial intelligence (AI) techniques. The Company develops healing chemical compounds from medical cannabis in combination with chemical compounds from psychedelic and edible mushrooms to treat conditions, such as cancer, depression, post-traumatic stress disorder (PTSD) and others, as well as opioid and alcohol addiction. The Company is also engaged in offering a water filtration system that incorporates mechanical filtration, membrane filtration, adsorption, silver infection control, ion exchange, and chemical additions into a three-stage water purification solution designed to meet the needs of consumers, business, and industries.
More about the company